ALB and hepatocellular carcinoma: Instead, Decitabine treatment interferes with Alb-R26Met cell tumorigenic properties, irrespective of the HCC cell line used, as exemplified by: (a) reduced colony numbers when cells are grown in an anchorage-independent manner (Fig. 2c); (b) reduced number and size of foci when cells are grown in an anchorage-dependent manner (Fig. 2d); (c) reduced tumour spheres when cells are grown in self-renewal conditions (Fig. 2e).